The Scientific Evidence for Using Ketamine to Treat Acute and Chronic Depression

One of the biggest downfalls in the conventional treatment of depression is the amount of time it takes for the drugs to take effect. Conventional antidepressants like SSRIs largely target the serotonin system—which has long been thought to be the hormone responsible for depression—but the medical community acknowledges that these medicines are far from ideal. […]

Continue Reading

Why Decriminalization Is the Harm Reduction Tactic We Need to Treat Society’s Drug Problem

In 1977, Kenya imposed a nationwide hunting ban in response to illegal poaching that was depleting the country’s elephant populations. Zimbabwe was facing a similar problem, but instead of a ban, they did nothing. The next decade showed a contradictory lesson in economics and sociology: Kenya’s elephant population continued to drop dramatically, almost 90%, while […]

Continue Reading

How Will We Train the Next Generation of Psychedelic Researchers and Therapists?

In MAPS’ proposal to the FDA for their MDMA-assisted psychotherapy research, director Rick Doblin wrote of their ongoing studies to treat PTSD: “At present, there are no parallels to [this research] because there are no psychoanalytic agents that therapists administer acutely to patients to enhance the psychotherapeutic process.” It’s true; there’s nothing quite like psychedelic […]

Continue Reading